Van ECK Associates Corp Purchases 2,755 Shares of Nano-X Imaging Ltd. (NASDAQ:NNOX)

Van ECK Associates Corp lifted its position in Nano-X Imaging Ltd. (NASDAQ:NNOXFree Report) by 14.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 22,293 shares of the company’s stock after buying an additional 2,755 shares during the period. Van ECK Associates Corp’s holdings in Nano-X Imaging were worth $164,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in NNOX. Olympiad Research LP lifted its position in Nano-X Imaging by 35.1% in the 4th quarter. Olympiad Research LP now owns 16,832 shares of the company’s stock valued at $107,000 after acquiring an additional 4,375 shares in the last quarter. Cantor Fitzgerald L. P. purchased a new position in Nano-X Imaging in the 4th quarter worth about $196,000. Virtu Financial LLC bought a new position in Nano-X Imaging during the 4th quarter valued at about $294,000. Tempus Wealth Planning LLC boosted its holdings in shares of Nano-X Imaging by 4.7% during the 1st quarter. Tempus Wealth Planning LLC now owns 105,215 shares of the company’s stock valued at $1,028,000 after acquiring an additional 4,750 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System boosted its holdings in shares of Nano-X Imaging by 17.5% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 16,000 shares of the company’s stock valued at $156,000 after acquiring an additional 2,380 shares during the last quarter. Hedge funds and other institutional investors own 21.49% of the company’s stock.

Nano-X Imaging Price Performance

NNOX stock opened at $6.00 on Tuesday. Nano-X Imaging Ltd. has a 1 year low of $4.89 and a 1 year high of $14.28. The company has a market cap of $346.67 million, a P/E ratio of -5.61 and a beta of 2.01. The stock’s fifty day moving average price is $7.36 and its 200-day moving average price is $8.57.

Nano-X Imaging (NASDAQ:NNOXGet Free Report) last announced its earnings results on Tuesday, August 20th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.01). Nano-X Imaging had a negative return on equity of 30.34% and a negative net margin of 567.41%. The firm had revenue of $2.70 million during the quarter. During the same quarter last year, the firm earned ($0.31) earnings per share. As a group, analysts expect that Nano-X Imaging Ltd. will post -0.88 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Cantor Fitzgerald reissued an “overweight” rating and set a $18.00 price objective on shares of Nano-X Imaging in a report on Wednesday, May 29th.

Check Out Our Latest Report on NNOX

About Nano-X Imaging

(Free Report)

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.

See Also

Want to see what other hedge funds are holding NNOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nano-X Imaging Ltd. (NASDAQ:NNOXFree Report).

Institutional Ownership by Quarter for Nano-X Imaging (NASDAQ:NNOX)

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.